NUT carcinoma (NC) is defined molecularly by rearrangement of the NUTM1 gene and is
most commonly driven by the BRD4-NUT oncoprotein. Patients are typically in their teens or …

NUT carcinoma (NC) is a rare, aggressive subtype of squamous cell carcinoma defined by
rearrangement of the NUTM1 (aka NUT) gene. NC is driven by NUT‐fusion oncoproteins …

NUT carcinoma (NC) is a rare and highly aggressive malignancy with a dismal prognosis
and a median survival of 6–9 months only. Although very few cases of NC are reported each …

ABSTRACT NUT carcinoma (NC) is an aggressive squamous tumor characterized by NUT
gene rearrangement, and the most common fusion form is BRD4-NUT. However, NC …

NUT carcinoma is a rare, aggressive cancer defined by rearrangements of the NUTM1 gene.
No routinely effective treatments of NUT carcinoma exist, despite harboring a targetable …

NUT carcinoma (NC) is a genetically defined, highly aggressive, and incurable squamous
cell carcinoma associated with chromosomal rearrangements of NUT, most commonly …

Background NUT carcinoma is an aggressive malignancy characterized by translocations in
the NUTM1 gene. There are currently no consensus treatment recommendations for NUT …

Poorly differentiated neoplasms lacking characteristic histopathologic features represent a
significant challenge to the pathologist for diagnostic classification. Classically, NUT …

NUT (midline) carcinoma is a rare, highly aggressive, poorly differentiated carcinoma that
characteristically harbors a rearrangement of the NUTM1 gene. Most of these tumors occur …

NUT carcinomas (NC) are very rare and highly aggressive tumors, molecularly defined by
an aberrant gene fusion involving the NUTM1 gene. NCs preferentially arise …